# Ophthalmic and Topical Dosage Form New Animal Drugs; Nystatin, Neomycin, Thiostrepton, and Triamcinolone Acetonide Ointment
> **Food and Drug Administration** · Final rule. · Published 2003-09-23 · Effective 2003-09-23 · 68 FR 55201
## Document
- **Document number:** 03-24160
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 68 FR 55201
- **CFR reference:** 21 CFR 524
- **Publication date:** 2003-09-23
- **Effective date:** 2003-09-23
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Altana, Inc. The ANADA provides for topical dermatologic use in dogs and cats of a nystatin, neomycin, thiostrepton, and triamcinolone acetonide ointment in a vanishing cream base.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2003/09/23/03-24160/ophthalmic-and-topical-dosage-form-new-animal-drugs-nystatin-neomycin-thiostrepton-and-triamcinolone)
---
*AI Analytics · CC0 1.0*